Misfolded pancreatic protein can induce symptoms of diabetes


Friday, 04 August, 2017

Misfolded pancreatic protein can induce symptoms of diabetes

US researchers have discovered that the symptoms of diabetes can be induced by a misfolded form of a pancreatic protein. The findings raise the possibility that type 2 diabetes can be transmitted by a mechanism similar to prion diseases such as Creutzfeldt-Jakob disease or bovine spongiform encephalopathy (mad cow disease).

Around 1 million Australian adults suffer from type 2 diabetes, a condition in which the body is unable to regulate blood glucose levels using the hormone insulin. Though the disease has been linked to a variety of genetic and environmental risk factors, the cause of type 2 diabetes is still not completely understood.

Over 90% of type 2 diabetes patients show abnormal protein deposits in their pancreatic islets that are mainly aggregates of a misfolded form of a protein called islet amyloid polypeptide (IAPP). The precise role of these IAPP aggregates in type 2 diabetes is unclear, but they may damage and kill the pancreatic β cells that secrete insulin in response to elevated blood glucose levels.

In this respect, type 2 diabetes could be similar to other diseases caused by misfolded protein aggregates, such as Alzheimer’s disease, Parkinson’s disease and prion disorders — a key feature of these diseases being that a small number of misfolded protein aggregates can serve as ‘seeds’ that induce the misfolding of additional proteins until they form large aggregates capable of damaging the cell. In the case of prion diseases, these seeds can even be transmitted from one individual to another.

Claudio Soto and colleagues at The University of Texas Health Science Center at Houston found that injecting small amounts of misfolded IAPP aggregates induced the formation of protein deposits in the pancreases of mice expressing human IAPP. Within weeks, these mice developed several symptoms associated with type 2 diabetes, including a loss of pancreatic β cells and elevated blood glucose levels. Small amounts of misfolded IAPP could also induce the formation and accumulation of large IAPP aggregates in pancreatic islets isolated from healthy human donors.

Writing in The Journal of Experimental Medicine, the study authors concluded that misfolded IAPP can induce protein aggregation and disease similarly to infectious prion proteins. Soto does however caution that it is much too soon to conclude that type 2 diabetes can be transmitted between individuals.

“Considering the experimental nature of the models and conditions utilised in this study, the results should not be extrapolated to conclude that type 2 diabetes is a transmissible disease in humans without additional studies,” he said.

Although there is anecdotal evidence of patients developing diabetes after organ transplantation, no epidemiological studies have been done to assess whether type 2 diabetes is a transmissible disease, the researchers noted. “Until now, this concept has not been considered,” Soto said.

“Our data therefore opens up an entirely new area of research, with profound implications for public health. Perhaps more important than a putative interindividual transmission, the prion-like mechanism may play a key role in the spreading of the pathology from cell to cell or islet to islet during the progression of type 2 diabetes.”

Image caption: A large protein aggregate (green) forms in a pancreatic islet (red) from a transgenic mouse injected with misfolded IAPP. Image credit: Mukherjee et al, 2017.

Related News

Stem cell experiments conducted in space

Scientists are one step closer to manufacturing stem cells in space — which could speed up...

Plug-and-play test evaluates T cell immunotherapy effectiveness

The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...

Common heart medicine may be causing depression

Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd